Format

Send to

Choose Destination
Am J Obstet Gynecol. 2018 Sep;219(3):235-241. doi: 10.1016/j.ajog.2018.07.013. Epub 2018 Jul 19.

Postpartum intrauterine devices: clinical and programmatic review.

Author information

1
Department of Obstetrics and Gynecology, Division of Family Planning Services and Research, Stanford University School of Medicine, Stanford, CA. Electronic address: lgoldthw@stanford.edu.
2
Department of Obstetrics and Gynecology, Division of Family Planning Services and Research, Stanford University School of Medicine, Stanford, CA.

Abstract

The immediate postpartum period is a critical moment for contraceptive access and an opportunity to initiate long-acting reversible contraception, which includes the insertion of an intrauterine device. The use of the intrauterine device in the postpartum period is a safe practice with few contraindications and many benefits. Although an intrauterine device placed during the postpartum period is more likely to expel compared with one placed at the postpartum visit, women who initiate intrauterine devices at the time of delivery are also more likely to continue to use an intrauterine device compared with women who plan to follow up for an interval intrauterine device insertion. This review will focus on the most recent clinical and programmatic updates on postpartum intrauterine device practice. We discuss postpartum intrauterine device expulsion and continuation, eligibility criteria and contraindications, safety in regards to breastfeeding, and barriers to access. Our aim is to summarize evidence related to postpartum intrauterine devices and encourage those involved in the healthcare system to remove barriers to this worthwhile practice.

KEYWORDS:

contraception; intrauterine device; postpartum

PMID:
30031750
DOI:
10.1016/j.ajog.2018.07.013

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center